Concepedia

Emily Beirne

EB

Statistics

Publications

4

Citations

234

H-Index

4

Active since

2015

Affiliations

Presage Biosciences (United States)(Current)

University of Washington

Fred Hutch Cancer Center

Emily Beirne is an author at Presage Biosciences (United States) specializing in pharmacology, oncology, and medicine.

ORCID

Publications per year

2015–2023

4

Publications

4

A technology platform to assess multiple cancer agents simultaneously within a patient’s tumor

Richard A. Klinghoffer, S-Bahram Bahrami, Beryl A. Hatton et al. · Science Translational Medicine · 2015 · 95 citations · Full text

, , +17

Voruciclib, a clinical stage oral CDK9 inhibitor, represses MCL-1 and sensitizes high-risk Diffuse Large B-cell Lymphoma to BCL2 inhibition

Joyoti Dey, Thomas L. Deckwerth, William Kerwin et al. · Scientific Reports · 2017 · 95 citations · Full text

, , +15

Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment

Jonathan M.J. Derry, Connor Burns, Jason P. Frazier et al. · Clinical Cancer Research · 2023 · 25 citations · Full text

, , +17

Multidrug Analyses in Patients Distinguish Efficacious Cancer Agents Based on Both Tumor Cell Killing and Immunomodulation

Jason P. Frazier, Jessica A. Bertout, William Kerwin et al. · Cancer Research · 2017 · 19 citations · Full text

, , +17

1–4 of 4